Sarcoma: open trials in Colombia

• NCT06395103

  Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

  Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC

  Clinica de la Costa S.A.S.-Clinical Research Oncology & Hematology -Pediatric ( Site 1924), Barranquilla · Hospital Pablo Tobon Uribe ( Site 1923), Medellín · IMAT S.A.S ( Site 1921), Montería

  Registry updated 2026-10-30

• NCT06345729

  A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

  Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC

  Clinica Oncologica Colsubsidio ( Site 4003), Bogota · Hemato Oncologos SA ( Site 4002), Cali · Oncologos del Occidente ( Site 4005), Pereira · Sociedad De Oncología y Hematología Del Cesar SAS ( Site 4000), Valledupar

  Registry updated 2026-10-26

• NCT07541170

  A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)

  Trial Treatment · Phase 3 · Hoffmann-La Roche

  Fundación CTIC - Centro de Tratamiento e Investigación sobre Cáncer Luis Carlos Sarmiento Angulo, Bogota, D.C. · Clinica ASTORGA, Medellín

  Registry updated 2026-10-13

• NCT05697874

  International Rare Brain Tumor Registry

  Research · Children's National Research Institute

  Clinica del Country, Bogota · HOMI - Fundación Hospital de la Misericordia, Bogotá

  Registry updated 2026-08-07

All Sarcoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error